35 search results for: IL-13
Exploring the Potential Role of Biomarkers in Managing Bullous Pemphigoid
Dr. Donna Culton discusses biomarkers in bullous pemphigoid and considers their potential clinical use.
The Type 2 Interface: Unifying AD, CSU, and PN Pathophysiology and Dispelling Common Misconceptions
This symposium highlights the central role of type 2 inflammation in atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria and dismantles prevalent scientific misconceptions about these inflammatory skin conditions with lively discussion from Drs Jason Hawkes, Lakshi Aldredge and Diego Dasilva.
Challenging Misconceptions for Better Patient Care in AD and PN: Insight into Type 2 Inflammation
This symposium explores the key role type 2 inflammation plays in atopic dermatitis and prurigo nodularis and debunks common misconceptions about these skin diseases with key insights from Drs Ahuva Cices and Naiem Issa.
The Type 2 Inflammatory Link in AD, CSU, and PN
Dr. Jason Hawkes explores the unique clinical manifestations of atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis, while highlighting the shared role of type 2 inflammation across these distinct diseases.
From Symptoms to Signaling: Type 2 Inflammation Underlying AD/PN
Dr. Naiem Issa examines the shared and distinct features of atopic dermatitis and prurigo nodularis, highlighting the role of type 2 inflammation in both diseases.
Shedding Light on PN: Confronting Misconception
Dr. Naiem Issa debunks common misconceptions in prurigo nodularis with key clinical insights.
Misconception on AD Pathomechanisms
Dr. Jason Hawkes provides key pathophysiologic insights and debunks common misconceptions surrounding atopic dermatitis.
Clarifying CSU: Separating Facts from Misconceptions
Dr. Diego Dasliva untangles popular misconceptions surrounding chronic spontaneous urticaria.
Dispelling Persistent Myths About PN
Dr. Lakshi Aldredge sets the record straight regarding common misconceptions about prurigo nodularis.
AD: Challenging the Conventional Narrative
Dr. Ahuva Cices provides key pathophysiologic insights and dispels common misconceptions surrounding atopic dermatitis.
Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
Listen as Dr. Donna Culton discusses the importance of crosstalk between autoantibodies and type 2 inflammation in the development of bullous pemphigoid.
Challenging Assumptions: Clarifying Type 2 Inflammation Across AD, PN, and CSU
In this webinar, Drs. David Cotter, Daniel Butler, and Walter Liszewski share key clinical insights, highlighting the central role of type 2 inflammation across atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria while addressing prevalent scientific misconceptions.
